22-24 October, 2018
Frankfurt, Germany

The Industry Definitive Forum
for Actionable Insights

Although 2018 marks over 150 companies and 190 pipeline products in development for NASH; there remains no approved treatment for this huge unmet medical need, and gaps in our understanding of how to efficaciously deliver one continue to exist.

The 2nd NASH Summit Europe fills the gap as the only industry-led forum dedicated to harnessing the NASH biopharmaceutical understanding and focusing on the most pressing drug development challenges with a tighter lens, including:

  • The potential for stand-alone versus combination therapeutics
  • The genetic drivers influencing disease heterogeneity
  • The future payer and reimbursement landscape

Built from research with 20 NASH stakeholders including the FDA, EMA and Gilead; the 2nd NASH Summit Europe brings together the leading experts in the only forum dedicated exclusively to collaborative discussion and networking for NASH drug developers.

Download the full event guide here

“Excellent opportunity to catch up with the field, hear other industry speakers present their work”
Genentech, 2nd NASH Summit, Boston

"Great event exceptional networking opportunities. High quality of presentations. Very efficient way to spend my time."
Synexus, 2nd NASH Summit, Boston

Media Partner